| 國立成功大學 |
2024-11-18 |
Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphoma
|
Tsai;Hui-Jen;Yeh;Kun-Huei;Lin;Chung-Wu;Wu;Ming-Shiang;Liou;Jyh-Ming;Hsu;Ping-Ning;Zeng;Yi-Shin;Wei;Ming-Feng;Shun;Chia-Tung;Wang;Hsiu-Po;Chen;Li-Tzong;Cheng;Ann-Lii;Kuo;Sung-Hsin |
| 國立成功大學 |
2024-11 |
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri
|
Boku;Narikazu;Omori;Takeshi;Shitara;Kohei;Sakuramoto;Shinichi;Yamaguchi;Kensei;Kato;Ken;Kadowaki;Shigenori;Tsuji;Kunihiro;Ryu;Min-Hee;Oh;Do-Youn;Oh;Cheul, Sang;Rha;Young, Sun;Lee;Keun-Wook;Chung;Ik-Joo;Sym;Jin, Sun;Chen;Li-Tzong;Chen;Jen-Shi;Bai;Li-Yuan;Nakada;Takashi;Hagihara;Shunsuke;Makino;Reina;Nishiyama;Eiji;Kang;Yoon-Koo |
| 國立成功大學 |
2024-08 |
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, pl
|
Kang;Yoon-Koo;Terashima;Masanori;Kim;Young-Woo;Boku;Narikazu;Chung;Cheol, Hyun;Chen;Jen-Shi;Ji;Jiafu;Yeh;Ta-Sen;Chen;Li-Tzong;Ryu;Min-Hee;Kim;Gwang, Jong;Omori;Takeshi;Rha;Young, Sun;Kim;Yong, Tae;Ryu;Won, Keun;Sakuramoto;Shinichi;Nishida;Yasunori;Fukushima;Norimasa;Yamada;Takanobu;Bai;Li-Yuan;Hirashima;Yoshinori;Hagihara;Shunsuke;Nakada;Takashi;Sasako;Mitsuru |
| 國立成功大學 |
2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
|
Oh;Do-Youn;He;Ruth, Aiwu;Bouattour;Mohamed;Okusaka;Takuji;Qin;Shukui;Chen;Li-Tzong;Kitano;Masayuki;Lee;Choong-kun;Kim;Won, Jin;Chen;-Huang, Ming;Suksombooncharoen;Thatthan;Ikeda;Masafumi;Lee;Ah, Myung;Chen;Jen-Shi;Potemski;Piotr;Burris;Howard, A.;Ostwal;Vikas;Tanasanvimon;Suebpong;Morizane;Chigusa;Zaucha;Renata, E.;Mcnamara;Mairead, G.;Avallone;Antonio;Cundom;Juan, E.;Breder;Valeriy;Tan;Benjamin;Shimizu;Satoshi;Tougeron;David;Evesque;Ludovic;Petrova;Mila;Zhen;David, B.;Gillmore;Roopinder;Gupta;Govinda, Vineet;Dayyani;Farshid;Park;Oh, Joon;Jr, Buchschacher;Gary, L.;Rey;Felipe;Kim;Hyosung;Wang;Julie;Morgan;Claire;Rokutanda;Nana;Zotkiewicz;Magdalena;Vogel;Arndt;Valle;Juan, W. |
| 國立成功大學 |
2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study
|
Tsai;Hui-Jen;Shan;Yan-Shen;Yang;Ching-Yao;Hsiao;Chin-Fu;Tsai;Chung-Hsin;Wang;Chuan-Cheng;Lin;Ming-Tsan;Ting;Chun-Fu;Chan;De-Chuan;Chen;Te-Hung;Yen;Chueh-Chuan;Chen;Yen-Yang;Lin;Hsuan-Yu;Yeh;Ta-Sen;Ho;Ching-Liang;Shieh;Tze-Yu;Bai;Li-Yaun;Hsu;Jun-Te;Chen;I-Shu;Chen;Li-Tzong;Yeh;Chun-Nan;Liu;Tsang-Wu;Chuang;Chieh-Han;Wang;Tsang-En |
| 國立成功大學 |
2024-06-21 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
|
Tsai;Hui-Jen;Yang;Shih-Hung;Hsiao;Chin-Fu;Kao;Hsiang-Fong;Su;Yung-Yeh;Shan;Yan-Shen;Yen;Chia-Jui;Du;Jeng-Shiun;Hsu;Chiun;Wu;I-Chen;Chen;Li-Tzong |
| 國立成功大學 |
2024-05 |
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer
|
Tang;Cheng-Yu;Yang;Shih-Hung;Li;Chung-Pin;Su;Yung-Yeh;Chiu;Sz-Chi;Bai;Li-Yuan;Shan;Yan-Shen;Chen;Li-Tzong;Chuang;Shih-Chang;Chan;De-Chuan;Yen;Chia-Jui;Peng;Cheng-Ming;Chiu;Tai-Jan;Chen;Yen-Yang;Chen;Jen-Shi;Chiang;Nai-Jung;Chou;Wen-Chi |
| 國立成功大學 |
2024-02-13 |
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
|
Cheng;Muk, Siao;Su;Yung-Yeh;Chiang;Nai-Jung;Wang;Chih-Jung;Chao;Ying-Jui;Huang;Chien-Jui;Tsai;Hui-Jen;Chen;Shang-Hung;Chang;Chi-Yen;Tsai;Chia-Rung;Li;Yi-Jie;Yen;Chia-Jui;Chuang;Shih-Chang;Chang;Jeffrey, Shu-Ming;Shan;Yan-Shen;Hwang;Daw-Yang;Chen;Li-Tzong |
| 國立成功大學 |
2023-09-1 |
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized
|
Chiu;Yen-Feng;Liu;Tsang-Wu;Shan;Yan-Shen;Chen;Jen-Shi;Li;Chung-Pin;Ho;Ching-Liang;Hsieh;Ruey-Kuen;Hwang;Tsann-Long;Chen;Li-Tzong;Chang;Hui-Ju |
| 國立成功大學 |
2023-09 |
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study
|
Su;Yung-Yeh;Chao;Ying-Jui;Wang;Chih-Jung;Liao;Ting-Kai;Su;Ping-Jui;Huang;Chien-Jui;Chiang;Nai-Jung;Yu;Yu-Ting;Tsai;Hong-Ming;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2023-08 |
The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study
|
Yen;Chih-Chieh;Yang;Yi-Hsin;Ku;Hsiu-Ying;Hu;Huang-Ming;Lo;Su-Shun;Chang;Hung-Chi;Chao;Yee;Chen;Jen-Shi;Wang;Hsiu-Po;Wang;Tsang-En;Bai;Li-Yuan;Wu;Ming-Shiang;Yen;Chia-Jui;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2023-02 |
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
|
Su;Yung-Yeh;Chiang;Nai-Jung;Yang;Yi-Hsin;Yen;Chia-Jui;Bai;Li-Yuan;Chiu;Chang-Fang;Chuang;Shih-Chang;Yang;Shih-Hung;Chou;Wen-Chi;Chen;Jen-Shi;Chiu;Tai-Jan;Chen;Yen-Yang;Chan;De-Chuan;Peng;Cheng-Ming;Chiu;Sz-Chi;Li;Chung-Pin;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2022-11-6 |
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation
|
Chang;Tsung-Ming;Chu;Pei-Yi;Lin;Hui-You;Huang;Kuo-Wei;Hung;Wen-Chun;Shan;Yan-Shen;Chen;Li-Tzong;Tsai;Hui-Jen |
| 國立成功大學 |
2022-10 |
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
|
Chiang;Nai-Jung;Hou;Ya-Chin;Tan;Thiam, Kien;Tsai;Hung-Wen;Lin;Yih-Jyh;Yeh;Yi-Chen;Chen;Li-Tzong;Hou;Ya-Fu;Chen;Ming-Huang;Shan;Yan-Shen |
| 國立成功大學 |
2022-06-22 |
Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study
|
Su;Yung-Yeh;Chiang;Nai-Jung;Li;Chung-Pin;Yen;Chia-Jui;Yang;Shih-Hung;Chou;Wen-Chi;Chen;Jen-Shi;Chiu;Tai-Jan;Chen;Yen-Yang;Chuang;Shih-Chang;Bai;Li-Yuan;Chiu;Chang-Fang;Peng;Cheng-Ming;Chan;De-Chuan;Chiu;Sz-Chi;Yang;Yi-Hsin;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2022-04-1 |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su;Yung-Yeh;Chiu;Yen-Feng;Li;Chung-Pin;Yang;Shih-Hung;Lin;Johnson;Lin;Shyh-Jer;Chang;Ping-Ying;Chiang;Nai-Jung;Shan;Yan-Shen;Ch'ang;Hui-Ju;Chen;Li-Tzong |
| 國立成功大學 |
2022 |
Original Article The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
|
Yang;Shih-Hung;Chiang;Nai-Jung;Chiu;Sz-Chi;Chou;Wen-Chi;Bai;Li-Yuan;Li;Chung-Pin;Su;Yung-Yeh;Chiu;Tai-Jan;Chuang;Shih-Chang;Peng;Cheng-Ming;Chan;De-Chuan;Chen;Jen-Shi;Yen;Chia-Jui;Chen;Yen-Yang;Chiu;Chang-Fang;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2021-11-12 |
The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors - A Single-Center Experience
|
Tsai;Hui-Jen;Hsiao;Chin-Fu;Chang;Jeffrey, S.;Chen;Li-Tzong;Chao;Ying-Jui;Yen;Chia-Ju;Shan;Yan-Shen |
| 國立成功大學 |
2021-07-23 |
AUY922 induces retinal toxicity through attenuating TRPM1
|
Shen;Che-Hung;Hsieh;Chi-Che;Jiang;Kuan-Ying;Lin;Chih-Yu;Chiang;Nai-Jung;Li;Ting-Wei;Yen;Chun-Ting;Chen;Wan-Ju;Hwang;Daw-Yang;Chen;Li-Tzong |
| 國立成功大學 |
2021-07 |
How May Ramucirumab Help Improve Treatment Outcome for Patients with Gastrointestinal Cancers?
|
Chen;Ming-Huang;Lu;Sheng-Nan;Chen;Chien-Hung;Lin;Peng-Chan;Jiang;Jeng-Kai;D'yachkova;Yulia;Lukanowski;Mariusz;Cheng;Rebecca;Chen;Li-Tzong |
| 國立成功大學 |
2021-05 |
Inhibition of beta-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice
|
Hsieh;Mei-Jen;Weng;Ching-Chieh;Lin;Yu-Chun;Wu;Chia-Chen;Chen;Li-Tzong;Cheng;Kuang-Hung |
| 國立成功大學 |
2021-04-12 |
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan
|
Chang;Jeffrey, S.;Chen;Li-Tzong;Shan;Yan-Shen;Chu;Pei-Yi;Tsai;Chia-Rong;Tsai;Hui-Jen |
| 國立成功大學 |
2021-03-1 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
|
Tsai;Hui-Jen;Shiah;Her-Shyong;Chang;Jang-Yang;Su;Wu-Chou;Chiang;Nai-Jung;Chen;Li-Tzong |
| 國立成功大學 |
2020-12-29 |
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
|
Chen;Chia-Yu;Liang;Shih-Hsin;Su;Yung-Yeh;Chiang;Nai-Jung;Wang;Hui-Ching;Chiu;Chang-Fang;Chen;Li-Tzong;Bai;Li-Yuan |
| 國立成功大學 |
2020-05-4 |
The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
|
Su;Yung-Yeh;Chiang;Nai-Jung;Tsai;Hui-Jen;Yen;Chia-Jui;Shan;Yan-Shen;Chen;Li-Tzong |
